therapeutic areas

Thought Leader Select Seeking New Sales Executive in U.S. Market

Thought Leader Select is looking for a dynamic, talented individual to fill its newest U.S. Sales Executive position. Founded in 2006, Thought Leader Select is a firm that serves the biopharmaceutical industry by providing strategic counsel on the best ways to work with medical experts (known as “thought leaders” and “key opinion leaders”) and assessing …

Thought Leader Select Seeking New Sales Executive in U.S. Market Read More »

Thought Leader Select Announces New KOL Identification and Profiling Projects in Oncology, Neurology

Thought Leader Select is pleased to announce a series of key opinion leader (KOL) identification and profiling projects to support multiple therapeutic areas for a top five global biopharmaceutical company. In these research assessments, Thought Leader Select will identify and profile leading medical experts in neurology and oncology to support drug development initiatives in various …

Thought Leader Select Announces New KOL Identification and Profiling Projects in Oncology, Neurology Read More »

Thought Leader Select’s Deep Profiling Identifies New KOLs, Rising Stars for Pharmaceutical Development

At Thought Leader Select, we employ a proprietary research methodology to identify key opinion leaders (KOLs) for pharmaceutical and biotechnology companies.  This methodology, known as deep profiling, enables biopharmaceutical firms to optimize teams of KOLs for different deployment areas throughout the development of new medicines and during the life cycles of their brands. At the …

Thought Leader Select’s Deep Profiling Identifies New KOLs, Rising Stars for Pharmaceutical Development Read More »

Thought Leader Select delivers KOL identification research to five leading pharma companies in the U.S. and Canada

April 15, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina-based firm dedicated to delivering solutions for key opinion leader (KOL) management for the biopharmaceutical industry, has announced the delivery of KOL identification projects for five leading North American pharmaceutical companies during the first quarter of 2010. Five of the world’s largest pharmaceutical concerns contracted …

Thought Leader Select delivers KOL identification research to five leading pharma companies in the U.S. and Canada Read More »

PharmExec's 2010 Forecast Reflected in Thought Leader Select's Current Projects

While 2010 continues to be a challenging year for the pharmaceutical industry as a whole, certain targeted areas of development continue to gain attention from the industry. In PharmExec’s 2010 forecast,Alexandra Kibble predicted continued focus on the following therapeutic areas:  cardiovascular, oncology, and anti-infectives.  Kibble also predicted a rise in pipeline development of treatments for …

PharmExec's 2010 Forecast Reflected in Thought Leader Select's Current Projects Read More »

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies

New press release out today, celebrating the tremendous efforts of our business development and research teams. FOR IMMEDIATE RELEASE March 9, 2009 (CHAPEL HILL, NC)  Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces on-going research …

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies Read More »